PTGX

121.4002.11%
DV

Dinesh V. Patel

CEO, President, Secretary & Director

Dr. Dinesh V. Patel, Ph.D., has been the Chief Executive Officer, President and Director at Protagonist Therapeutics, Inc. since December 2008 and serves as its Secretary. He serves as Non-Executive Independent Director at Sai Life Sciences Limited since March 24, 2025. He served as Interim Chief Financial Officer at Protagonist Therapeutics, Inc. until May 28, 2019 and was its Interim Principal Accounting Officer. Dr. Patel has executive, entrepreneurial and scientific experience spanning the pharmaceutical, biotechnology and biopharmaceutical industries. Dr. Patel served as Consultant of Arête Therapeutics, Inc. since July 2008. He served as Chief Executive of Arête Therapeutics Inc. from February 2006 to July 2008 and also served as its President from 2006 to July 2008. Dr. Patel Co-founded Miikana Therapeutics Inc., in 2002 and served as its President from 2003 to 2005 and served as its Chief Operating Officer. He was the Chief Executive Officer of Miikana Therapeutics, an oncology-based company, from 2003 until it was acquired by Entremed (later renamed CASI Pharmaceuticals) in 2005. He served as Senior Vice President of drug discovery and licensing of Vicuron Pharmaceuticals Inc., (formerly, Versicor) from 1996 to July 2003. Prior to Miikana, Dr. Patel held positions of increasing responsibility at Versicor (later renamed Vicuron and which was acquired by Pfizer in 2015), from 1996 to 2003. At Versicor, he led their internal and collaborative research programs (Pharmacia, Novartis) and actively participated in various financing activities. Dr. Patel served as Director of Drug Discovery of Affymax and led the combinatorial chemistry application efforts aimed at changing the drug discovery paradigm. Dr. Patel was a Medicinal Chemist at BristolMyers Squibb from 1985 and served in various positions including group leader. Dr. Patel has a proven track record of incubating and leading projects from ‘Targets to INDs’. He served as Director of Arête Therapeutics, Inc. until July 2008. He has more than 100 patents and publications to his credit. Dr. Patel was a Director of Chemistry at the combinatorial chemistry company Affymax, from 1993 to 1996. Dr. Patel received his Ph.D. in Organic Chemistry from Rutgers University, The State University of New Jersey and conducted Post-Doctoral research at the University of Wisconsin, Madison. He holds his M.Sc. and B.Sc. in Chemistry from S. P. University, Vallabh Vidyanagar, India.

Positions